Skip to content

INNOVATIVE EYEWEAR, INC.: 10-Q filed 2025-11-13

What INNOVATIVE EYEWEAR, INC. reported in its quarterly report filed 2025-11-13 (fiscal Q3 2025): 42 published measures, 123 facts as tagged in accession 0001829126-25-009128.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-13
Fiscal period
fiscal Q3 2025
Accession
0001829126-25-009128 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INNOVATIVE EYEWEAR, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3011,175,221USD
At 2024-12-319,838,309USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-30925,003USD
At 2024-12-31743,168USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-3010,250,218USD
At 2025-06-3011,277,254USD
At 2025-03-317,494,014USD
At 2024-12-319,095,141USD
At 2024-09-3010,930,925USD
At 2024-06-307,344,095USD
At 2024-03-313,901,569USD
At 2023-12-315,558,826USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-306,699,515USD
At 2024-12-312,628,987USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,836,267USD92
2025-01-01 to 2025-09-30-5,721,064USD273
2024-07-01 to 2024-09-30-1,720,677USD92
2024-01-01 to 2024-09-30-5,640,387USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-5,924,987USD273
2024-01-01 to 2024-09-30-4,796,361USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-09-3055,483USD273
2024-01-01 to 2024-09-3035,748USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-07-01 to 2025-09-30668,128USD92
2025-01-01 to 2025-09-301,701,859USD273
2024-07-01 to 2024-09-30253,599USD92
2024-01-01 to 2024-09-30945,752USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-306,344,438USD273
2024-01-01 to 2024-09-3010,153,476USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-303,651,077USD273
2024-01-01 to 2024-09-30-5,100,736USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-30,456,994USD
At 2024-12-31-24,735,930USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-304,870,014shares92
2025-01-01 to 2025-09-303,521,602shares273
2024-07-01 to 2024-09-301,736,803shares92
2024-01-01 to 2024-09-301,178,768shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-304,870,014shares92
2025-01-01 to 2025-09-303,521,602shares273
2024-07-01 to 2024-09-301,736,803shares92
2024-01-01 to 2024-09-301,178,768shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.38USD/shares92
2025-01-01 to 2025-09-30-1.62USD/shares273
2024-07-01 to 2024-09-30-0.99USD/shares92
2024-01-01 to 2024-09-30-4.78USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.38USD/shares92
2025-01-01 to 2025-09-30-1.62USD/shares273
2024-07-01 to 2024-09-30-0.99USD/shares92
2024-01-01 to 2024-09-30-4.78USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-07-01 to 2025-09-300USD92
2025-01-01 to 2025-09-300USD273
2024-07-01 to 2024-09-300USD92
2024-01-01 to 2024-09-300USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-3058,243USD
At 2024-12-31107,562USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-30532,017USD273
2024-01-01 to 2024-09-30510,534USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-3010,598,995USD
At 2024-12-319,238,216USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-30884,651USD
At 2024-12-31737,718USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-09-30421,491USD
At 2024-12-31451,302USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-3083,358USD
At 2024-12-31107,918USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,165,664USD92
2025-01-01 to 2025-09-306,448,395USD273
2024-07-01 to 2024-09-301,821,407USD92
2024-01-01 to 2024-09-305,872,483USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-301,633,115USD
At 2024-12-31831,757USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30244,837USD92
2025-01-01 to 2025-09-30452,705USD273
2024-07-01 to 2024-09-3059,344USD92
2024-01-01 to 2024-09-30121,471USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-07-01 to 2025-09-30423,291USD92
2025-01-01 to 2025-09-301,249,154USD273
2024-07-01 to 2024-09-30194,255USD92
2024-01-01 to 2024-09-30824,281USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-07-01 to 2025-09-30129,984USD92
2025-01-01 to 2025-09-30608,784USD273
2024-07-01 to 2024-09-30131,369USD92
2024-01-01 to 2024-09-30604,472USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-305,205,687shares
At 2024-12-312,452,632shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-306,699,515USD
At 2024-12-312,628,987USD
At 2024-09-304,543,826USD
At 2023-12-314,287,447USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-09-3040,707,160USD
At 2024-12-3133,831,046USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-09-30302,001USD
At 2024-12-31298,028USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-09-30243,758USD
At 2024-12-31190,466USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-09-3096,492USD
At 2024-12-3141,229USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,836,267USD92
2025-04-01 to 2025-06-30-2,106,094USD91
2025-01-01 to 2025-03-31-1,778,703USD90
2024-07-01 to 2024-09-30-1,720,677USD92
2024-04-01 to 2024-06-30-1,948,399USD91
2024-01-01 to 2024-03-31-1,971,311USD91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,277,308USD92
2025-01-01 to 2025-09-303,679,521USD273
2024-07-01 to 2024-09-301,121,972USD92
2024-01-01 to 2024-09-303,526,217USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-07-01 to 2025-09-3014,922USD92
2025-01-01 to 2025-09-3053,292USD273
2024-07-01 to 2024-09-3023,956USD92
2024-01-01 to 2024-09-3083,907USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-01-01 to 2025-09-3053,292USD273
2024-01-01 to 2024-09-3083,907USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-01-01 to 2025-09-3048,931USD273
2024-01-01 to 2024-09-3025,199USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-3084,560USD92
2025-01-01 to 2025-09-30274,626USD273
2024-07-01 to 2024-09-3041,386USD92
2024-01-01 to 2024-09-30110,625USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-10-01 to 2025-10-15291,000USD15

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-26,381USD273
2024-01-01 to 2024-09-30-37,429USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30801,358USD273
2024-01-01 to 2024-09-30381,946USD274

Inspect the source

Entity
INNOVATIVE EYEWEAR, INC. / CIK 0001808377
Captured
2026-09-21T17:28:18.416Z
SEC response SHA-256
9fc7393ebd196f2beb924747dc7d3d98543b6e23c133a8352b51c4bd7b9efb0a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001808377.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))